Sentinel Trust CO Lba Bristol Myers Squibb CO Transaction History

Sentinel Trust CO Lba

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $777,192 - $926,705	-17,225 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $1.27 Million - $1.64 Million	-25,955 Reduced 60.11%	17,225 $895,000
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $1.46 Million - $1.64 Million	-26,400 Reduced 37.94%	43,180 $0
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $3.52 Million - $4.38 Million	69,580 New	69,580 $0

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sentinel Trust CO Lba, based on Form 13F filings with the SEC.

Stay updated on Sentinel Trust CO Lba with notifications on news.